Literature DB >> 1496014

Conformation for a beta-cyclodextrin monosubstituted with a cyclic dipeptide.

B Di Blasio1, V Pavone, F Nastri, C Isernia, M Saviano, C Pedone, V Cucinotta, G Impellizzeri, E Rizzarelli, G Vecchio.   

Abstract

The structural characterization of a beta-cyclodextrin monosubstituted with the peptide cyclo(L-His-L-Leu) is reported. This work provides an x-ray example of a covalently bound group that folds in such a way that the terminal apolar side chain is retained in the hydrophobic interior of the cone-shaped cyclodextrin cavity. 6-Deoxy-6-cyclo(L-histidyl-L-leucyl)-beta-cyclodextrin crystallizes in the space group P1 with cell dimensions a = 14.728(8) A, b = 15.084(7) A, c = 18.182(10) A, alpha = 94.36(6) degrees, beta = 95.81(5) degrees, gamma = 116.08(9) degrees; overall isotropic agreement R = 10.6% for 5703 observed reflections (Fo greater than 3 sigma). The molecular structure consists of two independent molecules with the formula C54H86N4O36.7.25H2O. Each molecule assumes a "sleeping swan"-like overall shape with the hydrophobic leucine side chain inserted inside the cavity of the macrocycle. The two independent units give rise to a head-to-tail dimer linked by hydrogen bonds occurring between primary and secondary hydroxyl groups of the two monomers. The packing of the dimers produces cavities containing water molecules. There are infinite hydrophilic channels running in the crystal, which is similar to what is found in the structures of cyclic peptides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1496014      PMCID: PMC49677          DOI: 10.1073/pnas.89.15.7218

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  Thermoregulation in rats: opposing effects of thyrotropin releasing hormone and its metabolite histidyl-proline diketopiperazine.

Authors:  C Prasad; T Matsui; J Williams; A Peterkofsky
Journal:  Biochem Biophys Res Commun       Date:  1978-12-29       Impact factor: 3.575

2.  Inhibition of prolactin secretion by histidyl-proline-diketopiperazine.

Authors:  K Bauer; K J Gräf; A Faivre-Bauman; S Beier; A Tixier-Vidal; H Kleinkauf
Journal:  Nature       Date:  1978-07-13       Impact factor: 49.962

3.  Antagonism of ethanol narcosis by histidyl-proline diketopiperazine.

Authors:  C Prasad; T Matsui; A Peterkofsky
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

Review 4.  Artificial enzymes and enzyme models.

Authors:  R Breslow
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1986

5.  Inhibition of abstinence syndrome in opiate dependent mice by cyclo (His-Pro).

Authors:  H N Bhargava
Journal:  Life Sci       Date:  1981-03-16       Impact factor: 5.037

6.  Synthesis, characterization, and anorectic testing of the four stereoisomers of cyclo(histidylproline).

Authors:  M J Kukla; H J Breslin; C R Bowden
Journal:  J Med Chem       Date:  1985-11       Impact factor: 7.446

7.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

8.  Effect of oxygen-derived free radicals on hyaluronic acid.

Authors:  R A Greenwald; W W Moy
Journal:  Arthritis Rheum       Date:  1980-04

9.  Arrangement of water molecules in cavities and channels of the lattice of [Phe4Val6]antamanide dodecahydrate.

Authors:  I L Karle; E Duesler
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.